Previous Article | Next Article ![]()
Molecular and Cellular Biology, March 2007, p. 2266-2282, Vol. 27, No. 6
0270-7306/07/$08.00+0 doi:10.1128/MCB.01439-06

Christine M. Jewell,1
Rachelle J. Bienstock,2
Jennifer B. Collins,3 and
John A. Cidlowski1*
Laboratory of Signal Transduction,1 Scientific Computing Laboratory,2 NIEHS Microarray Facility, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, 111 TW Alexander Drive, Research Triangle Park, North Carolina 277093
Received 4 August 2006/ Returned for modification 1 September 2006/ Accepted 5 January 2007
Human
glucocorticoid receptor (hGR) is expressed as two alternately spliced
C-terminal isoforms,
and ß. In contrast to the
canonical hGR
, hGRß is a nucleus-localized orphan
receptor thought not to bind ligand and not to affect gene
transcription other than by acting as a dominant negative to
hGR
. Here we used confocal microscopy to examine the cellular
localization of transiently expressed fluorescent protein-tagged
hGRß in COS-1 and U-2 OS cells. Surprisingly, yellow
fluorescent protein (YFP)-hGRß was predominantly located in the
cytoplasm and translocated to the nucleus following application of the
glucocorticoid antagonist RU-486. This effect of RU-486 was confirmed
with transiently expressed wild-type hGRß. Confocal microscopy
of coexpressed YFP-hGRß and cyan fluorescent
protein-hGR
in COS-1 cells indicated that the receptors move
into the nucleus independently. Using a ligand binding assay, we
confirmed that hGRß bound RU-486 but not the hGR
ligand dexamethasone. Examination of the cellular localization of
YFP-hGRß in response to a series of 57 related compounds
indicated that RU-486 is thus far the only identified ligand that
interacts with hGRß. The selective interaction of RU-486 with
hGRß was also supported by molecular modeling and computational
docking studies. Interestingly, microarray analysis indicates that
hGRß, expressed in the absence of hGR
, can regulate
gene expression and furthermore that occupation of hGRß with
the antagonist RU-486 diminishes that capacity despite the lack of
helix 12 in the ligand binding
domain.
Published ahead of print on 22 January 2007.
Present
address: Department of Cancer Biology, Mayo Clinic, 4500 San Pablo
Road, Jacksonville, FL 32224.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»